Healthcare provider profile · identity verified

Jane M Ziemanski, NP

Nurse Practitioner · MOSINEE, WI · NPI 1790873867

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	426	127
Losartan Potassium	Losartan Potassium	327	97
Levothyroxine Sodium	Levothyroxine Sodium	303	80
Metoprolol Succinate	Metoprolol Succinate	297	85
Amlodipine Besylate	Amlodipine Besylate	285	85
Gabapentin	Gabapentin	267	53
Lisinopril	Lisinopril	252	79
Hydrochlorothiazide	Hydrochlorothiazide	190	60
Omeprazole	Omeprazole	185	64
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	22
Simvastatin	Simvastatin	148	42
Metoprolol Tartrate	Metoprolol Tartrate	144	47
Pantoprazole Sodium	Pantoprazole Sodium	133	45
Metformin Hcl	Metformin Hcl	130	41
Furosemide	Furosemide	122	33
Tamsulosin Hcl	Tamsulosin Hcl	117	29
Eliquis	Apixaban	111	27
Tramadol Hcl	Tramadol Hcl	107	20
Albuterol Sulfate Hfa	Albuterol Sulfate	105	47
Prednisone	Prednisone	104	58
Potassium Chloride	Potassium Chloride	103	29
Sertraline Hcl	Sertraline Hcl	103	31
Allopurinol	Allopurinol	95	30
Rosuvastatin Calcium	Rosuvastatin Calcium	95	32
Hydralazine Hcl	Hydralazine Hcl	88	19
Metformin Hcl Er	Metformin Hcl	86	23
Pravastatin Sodium	Pravastatin Sodium	84	26
Alprazolam	Alprazolam	83	18
Trazodone Hcl	Trazodone Hcl	59	12
Fluoxetine Hcl	Fluoxetine Hcl	58	22
Fluticasone Propionate	Fluticasone Propionate	58	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	41
Amoxicillin	Amoxicillin	53	32
Lorazepam	Lorazepam	53	suppressed
Montelukast Sodium	Montelukast Sodium	50	14
Warfarin Sodium	Warfarin Sodium	50	14
Meloxicam	Meloxicam	47	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	15
Clopidogrel	Clopidogrel Bisulfate	43	13
Memantine Hcl	Memantine Hcl	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	13
Azithromycin	Azithromycin	41	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	13
Famotidine	Famotidine	41	suppressed
Glipizide	Glipizide	41	11
Glimepiride	Glimepiride	40	14
Ezetimibe	Ezetimibe	38	13
Chlorthalidone	Chlorthalidone	37	16
Triamcinolone Acetonide	Triamcinolone Acetonide	37	26
Estradiol	Estradiol	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	25
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Nystatin	Nystatin	33	12
Spironolactone	Spironolactone	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	12
Propranolol Hcl	Propranolol Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	11
Spiriva Respimat	Tiotropium Bromide	28	suppressed
Atenolol	Atenolol	27	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	27	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Carvedilol	Carvedilol	24	suppressed
Phenobarbital	Phenobarbital	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Methylprednisolone	Methylprednisolone	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	11
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nyamyc	Nystatin	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Enbrel Sureclick	Etanercept	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Nitroglycerin	Nitroglycerin	12	12
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	suppressed
Topiramate	Topiramate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Finasteride	Finasteride	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error